CRISPR-based gene editing therapy approved by the FDA for the first time

FDA approves a CRISPR-based medicine for treatment of sickle cell disease- In historic decision

Snapchat+ keeps growing as net revenue tops $20M for first time

The Race To 5G is Over - Now It's Time To Pay the Bill